Related references
Note: Only part of the references are listed.Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular Assays
Roland A. Cooper et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Impact of Antimalarial Treatment and Chemoprevention on the Drug Sensitivity of Malaria Parasites Isolated from Ugandan Children
Patrick Tumwebaze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study
Steve M. Taylor et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Temporal Changes in Prevalence of Molecular Markers Mediating Antimalarial Drug Resistance in a High Malaria Transmission Setting in Uganda
George W. Mbogo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Impact of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren: A Randomized, Placebo-Controlled Trial
Joaniter I. Nankabirwa et al.
CLINICAL INFECTIOUS DISEASES (2014)
Directional Selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu Loci of Plasmodium falciparum in Kenyan Children Treated With ACT
Gisela Henriques et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children
Melissa D. Conrad et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda
Maxwell Kilama et al.
MALARIA JOURNAL (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children
Melissa D. Conrad et al.
PLOS ONE (2014)
Protective Efficacy and Safety of Three Antimalarial Regimens for the Prevention of Malaria in Young Ugandan Children: A Randomized Controlled Trial
Victor Bigira et al.
PLOS MEDICINE (2014)
Optimization of a Ligase Detection Reaction-Fluorescent Microsphere Assay for Characterization of Resistance-Mediating Polymorphisms in African Samples of Plasmodium falciparum
Norbert P. LeClair et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
The interplay between drug resistance and fitness in malaria parasites
Philip J. Rosenthal
MOLECULAR MICROBIOLOGY (2013)
Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya
Steffen Borrmann et al.
SCIENTIFIC REPORTS (2013)
Prolonged Selection of pfmdr1 Polymorphisms After Treatment of Falciparum Malaria With Artemether-Lumefantrine in Uganda
Frederick N. Baliraine et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
Colin J. Sutherland et al.
PARASITOLOGY (2011)
A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial
Daniel Atwine et al.
PLOS MEDICINE (2011)
Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance
Obaro S. Michael et al.
MALARIA JOURNAL (2010)
Randomized, multicentre assessment of the efficacy and safety of ASAQ - a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
Jean Louis Ndiaye et al.
MALARIA JOURNAL (2009)
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up
George O. Adjei et al.
MALARIA JOURNAL (2008)
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda
Adoke Yeka et al.
PLOS ONE (2008)
An Open Label, Randomised Trial of Artesunate plus Amodiaquine, Artesunate plus Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria
Seth Owusu-Agyei et al.
PLOS ONE (2008)
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria
C. O. Falade et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania
Abdunoor M. Kabanywanyi et al.
MALARIA JOURNAL (2007)
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda
Samuel L. Nsobya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Combination therapy for uncomplicated falciparum malaria in Ugandan children - A randomized trial
Grant Dorsey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial
Issaka Zongo et al.
LANCET (2007)
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria
G. S. Humphreys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda
Hasifa Bukirwa et al.
PLOS CLINICAL TRIALS (2006)
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance
D Francis et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania
A Mårtensson et al.
CLINICAL INFECTIOUS DISEASES (2005)
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum
ABS Sidhu et al.
MOLECULAR MICROBIOLOGY (2005)
Amodiaquine alone, amodiaquine plus sulfadoxine-pyrimethamine, amodiaquine plus artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial
TK Mutabingwa et al.
LANCET (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
MB Reed et al.
NATURE (2000)
Share Paper
